The CD68 Market is benefiting from the increasing adoption of multiplex immunohistochemistry. Combining CD68 with other cellular markers enables researchers to characterize immune-cell populations and examine their spatial relationships within tissue samples.
The CD68 Market was valued at US$ 804.62 million in 2025 and is expected to reach US$ 1,563.69 million by 2034, registering a CAGR of...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek